Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Rhythm Pharmaceuticals In...

    NASDAQ: RYTM · Real-Time Price · USD
    62.34
    -0.56 (-0.89%)
    At close: Jun 16, 2025, 3:59 PM
    63.20
    1.38%
    After-hours: Jun 16, 2025, 06:52 PM EDT

    Rhythm Pharmaceuticals Statistics

    Share Statistics

    Rhythm Pharmaceuticals has 63.62M shares outstanding. The number of shares has increased by 3.69% in one year.

    Shares Outstanding

    n/a
    		 63.62M

    Shares Change (YoY)

    n/a
    		 3.69%

    Shares Change (QoQ)

    n/a
    		 2.87%

    Owned by Institutions (%)

    n/a
    		 99.99%

    Shares Floating

    n/a
    		 58.22M

    Failed to Deliver (FTD) Shares

    n/a
    		 1,444

    FTD / Avg. Volume

    n/a
    		 0.2%

    Short Selling Information

    The latest short interest is 4.78M, so 7.51% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 4.78M

    Short % of Shares Out

    n/a
    		 7.51%

    Short % of Float

    n/a
    		 9.75%

    Short Ratio (days to cover)

    n/a
    		 9.25

    Valuation Ratios

    The PE ratio is -13.1 and the forward PE ratio is -45.59. Rhythm Pharmaceuticals's PEG ratio is -0.42.

    PE Ratio

    n/a
    		 -13.1

    Forward PE

    n/a
    		 -45.59

    PS Ratio

    n/a
    		 26.24

    Forward PS

    n/a
    		 2.7

    PB Ratio

    n/a
    		 157.14

    P/FCF Ratio

    n/a
    		 -29.98

    PEG Ratio

    n/a
    		 -0.42
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Rhythm Pharmaceuticals.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 3.24, with a Debt / Equity ratio of 0.18.

    Current Ratio

    n/a
    		 3.24

    Quick Ratio

    n/a
    		 3.08

    Debt / Equity

    n/a
    		 0.18

    Debt / EBITDA

    n/a
    		 -0.02

    Debt / FCF

    n/a
    		 -0.03

    Interest Coverage

    n/a
    		 -12.89

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $459,809.19

    Profits Per Employee

    n/a
    		 $-920,855.12

    Employee Count

    n/a
    		 283

    Asset Turnover

    n/a
    		 0.33

    Inventory Turnover

    n/a
    		 0.71

    Taxes

    Income Tax

    n/a
    		 346K

    Effective Tax Rate

    n/a
    		 -0.13%

    Stock Price Statistics

    The stock price has increased by 51.46% in the last 52 weeks. The beta is 2.3, so Rhythm Pharmaceuticals's price volatility has been higher than the market average.

    Beta

    n/a
    		 2.3

    52-Week Price Change

    n/a
    		 51.46%

    50-Day Moving Average

    n/a
    		 61.67

    200-Day Moving Average

    n/a
    		 56.25

    Relative Strength Index (RSI)

    n/a
    		 48.43

    Average Volume (20 Days)

    n/a
    		 720,965

    Income Statement

    In the last 12 months, Rhythm Pharmaceuticals had revenue of 130.13M and earned -260.6M in profits. Earnings per share was -4.21.

    Revenue

    n/a
    		 130.13M

    Gross Profit

    n/a
    		 116.76M

    Operating Income

    n/a
    		 -265.5M

    Net Income

    n/a
    		 -260.6M

    EBITDA

    n/a
    		 -238.09M

    EBIT

    n/a
    		 -239.65M

    Earnings Per Share (EPS)

    n/a
    		 -4.21
    Full Income Statement

    Balance Sheet

    The company has 89.14M in cash and 3.94M in debt, giving a net cash position of 85.2M.

    Cash & Cash Equivalents

    n/a
    		 89.14M

    Total Debt

    n/a
    		 3.94M

    Net Cash

    n/a
    		 85.2M

    Retained Earnings

    n/a
    		 -1.16B

    Total Assets

    n/a
    		 386.69M

    Working Capital

    n/a
    		 257.46M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -113.88M and capital expenditures 0, giving a free cash flow of -113.88M.

    Operating Cash Flow

    n/a
    		 -113.88M

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 -113.88M

    FCF Per Share

    n/a
    		 -1.87
    Full Cash Flow Statement

    Margins

    Gross margin is 89.73%, with operating and profit margins of -204.04% and -200.27%.

    Gross Margin

    n/a
    		 89.73%

    Operating Margin

    n/a
    		 -204.04%

    Pretax Margin

    n/a
    		 -200%

    Profit Margin

    n/a
    		 -200.27%

    EBITDA Margin

    n/a
    		 -182.97%

    EBIT Margin

    n/a
    		 -204.04%

    FCF Margin

    n/a
    		 -87.51%

    Dividends & Yields

    RYTM does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for RYTM is $73.5, which is 17.9% higher than the current price. The consensus rating is "Strong Buy".

    Price Target

    n/a
    		 $73.5

    Price Target Difference

    n/a
    		 17.9%

    Analyst Consensus

    n/a
    		 Strong Buy

    Analyst Count

    n/a
    		 12
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 6.06

    Piotroski F-Score

    n/a
    		 4

    Add to Watchlist